Mackenzie Financial’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $311K | Sell |
11,283
-20,158
| -64% | -$556K | ﹤0.01% | 1381 |
|
|
2025
Q1 | $891K | Buy |
31,441
+3,922
| +14% | +$111K | ﹤0.01% | 1013 |
|
|
2024
Q4 | $1.14M | Sell |
27,519
-2,687
| -9% | -$112K | ﹤0.01% | 911 |
|
|
2024
Q3 | $2.02M | Sell |
30,206
-17,432
| -37% | -$1.16M | ﹤0.01% | 719 |
|
|
2024
Q2 | $5.66M | Sell |
47,638
-4,005
| -8% | -$476K | 0.01% | 522 |
|
|
2024
Q1 | $5.5M | Sell |
51,643
-63,364
| -55% | -$6.75M | 0.01% | 538 |
|
|
2023
Q4 | $11.4M | Buy |
115,007
+46,964
| +69% | +$4.67M | 0.02% | 415 |
|
|
2023
Q3 | $7.01M | Buy |
68,043
+2,135
| +3% | +$220K | 0.01% | 483 |
|
|
2023
Q2 | $8.02M | Buy |
65,908
+938
| +1% | +$114K | 0.01% | 482 |
|
|
2023
Q1 | $9.98M | Sell |
64,970
-19,259
| -23% | -$2.96M | 0.02% | 445 |
|
|
2022
Q4 | $15.1M | Sell |
84,229
-7,034
| -8% | -$1.26M | 0.03% | 345 |
|
|
2022
Q3 | $10.8M | Sell |
91,263
-4,676
| -5% | -$553K | 0.02% | 398 |
|
|
2022
Q2 | $13.7M | Buy |
95,939
+3,063
| +3% | +$438K | 0.02% | 387 |
|
|
2022
Q1 | $16M | Buy |
92,876
+25,299
| +37% | +$4.36M | 0.02% | 397 |
|
|
2021
Q4 | $17.2M | Sell |
67,577
-299
| -0.4% | -$75.9K | 0.02% | 391 |
|
|
2021
Q3 | $26.1M | Buy |
67,876
+352
| +0.5% | +$135K | 0.04% | 305 |
|
|
2021
Q2 | $15.9M | Buy |
67,524
+4,141
| +7% | +$973K | 0.02% | 372 |
|
|
2021
Q1 | $8.3M | Buy |
63,383
+11,198
| +21% | +$1.47M | 0.01% | 447 |
|
|
2020
Q4 | $5.45M | Sell |
52,185
-11,589
| -18% | -$1.21M | 0.01% | 432 |
|
|
2020
Q3 | $4.51M | Buy |
63,774
+12,033
| +23% | +$851K | 0.01% | 415 |
|
|
2020
Q2 | $3.32M | Buy |
+51,741
| New | +$3.32M | 0.01% | 459 |
|